Andrew Knudten

Andrew Knudten is a highly experienced professional who currently serves as the Chief Executive Officer at Advanced Medicine Partners. With a background in gene therapy and pharmaceutical operations, Andrew has held various leadership roles in companies such as Jaguar Gene Therapy, Cirius Therapeutics, AveXis, Inc., and Hospira. Andrew also founded Gene Therapy Consulting, LLC, where Andrew provided strategic advice to companies in the gene and cell therapy sector. Andrew holds a Master's degree in Cell Biology and Genetics from the University of Nebraska-Lincoln and an MBA from UCLA Anderson School of Management.